CorMedix Inc.
CRMD
$6.36
-$0.02-0.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 4.13% | 4,009.64% | 240.11% | 242.71% | 191.26% |
| Total Depreciation and Amortization | 7,692.16% | 4,797.29% | 111.83% | 642.66% | 616.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,775.25% | -4,515.37% | 108.42% | 43.01% | 9.34% |
| Change in Net Operating Assets | 246.94% | -109.99% | 676.07% | 13.66% | -851.84% |
| Cash from Operations | 1,782.33% | 326.06% | 313.62% | 214.02% | 47.75% |
| Capital Expenditure | -16,930.69% | -5,061.22% | 31.32% | 83.36% | 96.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,300.61% | 203.06% | -420.27% | -102.05% | -132.86% |
| Cash from Investing | 1,184.90% | -4,708.48% | -422.43% | -102.18% | -150.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -59.26% | -90.57% | 6,880.16% | -- | 2,324.33% |
| Repurchase of Common Stock | -382.02% | -- | -77.42% | -949.43% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -112.52% | 969.54% | 7,778.31% | 6,374.87% | 2,312.91% |
| Foreign Exchange rate Adjustments | 13.33% | -25.00% | 900.00% | 125.00% | -162.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,695.78% | -1,729.55% | 1,485.34% | 402.89% | 155.44% |